Evidence map›Paper›PMID 34007956›Full record

ArticleMayo Clinic proceedings. Innovations, quality & outcomes2021

Noninvasive Vocal Biomarker is Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Elad Maor, Nir Tsur, Galia Barkai, Ido Meister, Shmuel Makmel, Eli Friedman, Daniel Aronovich, Dana Mevorach, Amir Lerman, Eyal Zimlichman and 1 more

Abstract read
In one paragraph

Article in Mayo Clinic proceedings. Innovations, quality & outcomes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Voice Features of Sustained Phoneme as COVID-19 Biomarker.IEEE journal of translational engineering in health and medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Elad MaorLeviev Heart Center, Sheba Medical Center, Tel Hashomer, Israel.
Nir TsurDepartment of Otolaryngology, Head and Neck Surgery, Rabin and Schneider Medical Center, Petah Tikva, Israel.
Galia BarkaiDepartment of Otolaryngology, Head and Neck Surgery, Rabin and Schneider Medical Center, Petah Tikva, Israel.
Ido MeisterDirectorate of Defense Research and Development, Ministry of Defense, Be'er Sheva, Israel.
Shmuel MakmelDirectorate of Defense Research and Development, Ministry of Defense, Be'er Sheva, Israel.
Eli FriedmanDirectorate of Defense Research and Development, Ministry of Defense, Be'er Sheva, Israel.
Daniel AronovichVocalis Health, Tel Aviv, Israel.
Dana MevorachVocalis Health, Tel Aviv, Israel.
Amir LermanDepartment of Cardiovascular Diseases, Mayo College of Medicine, Rochester, MN.
Eyal ZimlichmanLeviev Heart Center, Sheba Medical Center, Tel Hashomer, Israel.
Gideon BacharSackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the association of voice analysis with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. PATIENTS AND

methodsA vocal biomarker, a unitless scalar with a value between 0 and 1, was developed based on 434 voice samples. The biomarker training was followed by a prospective, multicenter, observational study. All subjects were tested for SARS-CoV-2, had their voice recorded to a smartphone application, and gave their informed consent to participate in the study. The association of SARS-CoV-2 infection with the vocal biomarker was evaluated.

resultsThe final study population included 80 subjects with a median age of 29 [range, 23 to 36] years, of whom 68% were men. Forty patients were positive for SARS-CoV-2. Infected patients were 12 times more likely to report at least one symptom (odds ratio, 11.8;

conclusionVoice analysis is associated with SARS-CoV-2 status and holds the potential to improve the accuracy of self-reported symptom-based screening tools. This pilot study suggests a possible role for vocal biomarkers in screening for SARS-CoV-2-infected subjects.

Indexed as

AUC, area under the receiver operating curveCOVID-19, coronavirus disease 2019PCR, polymerase chain reactionSARS-CoV-2, severe acute respiratory syndrome coronavirus 2

Identifiers

PMID34007956
PMCPMC8120447

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.